SlideShare a Scribd company logo
1 of 26
EU SubmissionsBy,CHANDRAMOHAN
• Introduction
• European union member states
• Committees of EMEA
• Marketing authorization procedures
 Centralized procedure (CP)
 National procedure (NP)
 Mutual recognition procedure (MRP)
 Decentralized procedure (DCP)
EUROPE
Introduction to the EMA
• Prior to 2004, it was known as the European Agency for the Evaluation of
Medicinal Products or European Medicines Evaluation Agency (EMEA)
• The European Medicines Agency (EMA) is a decentralised agency of the
European Union (EU), located in London. It began operating in 1995. The Agency
is responsible for the scientific evaluation, supervision and safety monitoring of
medicines in the EU.
• EMA protects public and animal health in 28 EU Member States, as well as the
countries of the European Economic Area, by ensuring that all medicines available
on the EU market are safe, effective and of high quality.
European union member states
Belgium (BE) Greece (EL) Lithuania (LT) Portugal (PT)
Bulgaria (BG) Spain (ES) Luxembourg (LU) Romania (RO)
Czech Republic (CZ) France (FR) Hungary (HU) Slovenia (SI)
Denmark (DK) Croatia (HR) Malta (MT) Slovakia (SK)
Germany (DE) Italy (IT) Netherlands (NL) Finland (FI)
Estonia (EE) Cyprus (CY) Austria (AT) Sweden (SE)
Ireland (IE) Latvia (LV) Poland (PL) United Kingdom (UK)
European free trade association
Iceland (IS) Norway (NO)
Liechtenstein (LI) Switzerland (CH)
United Kingdom’s (UK) withdrawal from the EU
• EMA has published important information to help users of the centralised
procedure prepare for the expected consequences of 'Brexit', including their
obligations related to establishment within the European Economic Area (EEA).
For more information, see UK’s withdrawal from the EU.
• On 29 March 2017, the United Kingdom (UK) notified the European Council of
its intention to withdraw from the European Union (EU), a process known as
'Brexit'. The European Medicines Agency (EMA) is making preparations to ensure
that it can continue to deliver on its mission and protect public and animal health
after the UK leaves the EU on 30 March 2019, the date currently set by the
timeframe provided in Article 50 of the Treaty on European Union.
• One of the consequences of Brexit is that EMA will relocate to Amsterdam, the
Netherlands, where it has to take up its operations on 30 March 2019 at the latest.
REGULATORY BODY - EMA
 European medical Agency (EMA):
 Decentralized body of EU with headquarters in London (going to move
Amsterdam)
 Protection and promotion of public and animal health, through the
evaluation and supervision of medicines for human and veterinary use
 There are 7 scientific committees works under EMA in EU and EEA-
EFTA
Committees of EMEA
Committee for Medicinal Products for Human Use (CHMP)
Pharmacovigilance Risk Assessment Committee (PRAC)
 Committee for Medicinal Products for Veterinary Use (CVMP)
 Committee for Orphan Medicinal Products (COMP)
 Committee on Herbal Medicinal Products (HMPC)
 Pediatric Committee (PDCO)
 Committee for Advanced Therapies (CAT)
MARKETING AUTHORIZATION PROCEDURES
 CENTRALIZED PROCEDURE (CP)
 NATIONAL PROCEDURE (NP)
 MUTUAL RECOGNITION PROCEDURE (MRP)
 DECENTRALIZED PROCEDURE (DCP)
CENTRALIZED PROCEDURE
 Under the centralised authorisation procedure, pharmaceutical companies submit
a single marketing-authorisation application to EMA.
 This allows the marketing-authorisation holder to market the medicine throughout the
EU.
 MA's Committee for Medicinal products for Human Use (CHMP) or Committee for
Medicinal products for Veterinary Use (CVMP) carry out a scientific assessment of the
application and give a recommendation on whether the medicine should be marketed or
not.
 Once granted by the European Commission, the centralised marketing authorisation
is valid in all EU Member States as well as in the European Economic Area (EEA)
countries Iceland, Liechtenstein and Norway.
CENTRALIZED PROCEDURE
The centralised procedure is mandatory for:
 Human medicines containing a new active substance to treat:
HIV or AIDS; Cancer; Diabetes; Neurodegenerative diseases; Viral diseases; auto-immune and other
immune dysfunctions;
 Medicines derived from biotechnology processes, such as genetic engineering;
 Advanced-therapy medicines such as gene-therapy, somatic cell-therapy or tissue-
engineered medicines;
 Orphan medicines (medicines for rare diseases);
 Veterinary medicines for use as growth or yield enhancers.
CENTRALIZED PROCEDURE
CENTRALIZED PROCEDURE - Timelines
NATIONAL PROCEDURE
 Marketing authorization in one particular EU country
 Each EU Member State has its own national authorisation procedures.
 Approval time for drug product varies within member states of EU
 Applicable to abridged drug products
 Not applicable to biotechnology products
 Can also serve as the first phase of a Mutual Recognition procedure
 National abridged standard and complex applications takes approximately 210
days to be approved in UK
List of national competent authorities in the EEA:
Country Name Contact details Logo
Austria
Austrian
Agency for
Health and
Food Safety
Spargelfeldstraße 191
1220 Wien
Austria
Tel. +43 5 0555-0
Fax +43 5 0555-22019
www.ages.at
Belgium
Federal Agency
for Medicines
and Health
Products
Eurostation building, block 2
place Victor Horta, 40/ 40
1060 Brussels
Belgium
Tel. +32 2 524 7111
E-mail: info.medicines@fagg-
afmps.be
www.fagg-afmps.be/
Bulgaria
Bulgarian Drug
Agency
8 Damyan Gruev Str.
Sofia 1303
Bulgaria
Tel. +359 2 890 35 55
Fax +359 2 890 34 34
E-mail: bda@bda.bg
www.bda.bg
Croatia
Agency for
medicinal
products and
medical devices
of Croatia
Ksaverska cesta 4
10 000 Zagreb
Tel. +385 1 4884 100
Fax: +385 1 4884 110
E-mail: halmed@halmed.hr
www.almp.hr
Cyprus
Ministry of
Health -
Pharmaceutical
Services
Pharmaceutical Services
Ministry of Health
1475 Nicosia
Cyprus
Tel: +357 22608620
Fax: +357 22608649
E-mail: phscentral@phs.moh.gov.cy
www.moh.gov.cy/phs
Czech
Republic
State Institute
for Drug
Control
Srobárova 48
100 41 Praha 10
Czech Republic
Tel. +420 272 185 333
Fax +420 272 185 756
E-mail: infs@sukl.cz
www.sukl.cz
Denmark
Danish
Medicines
Agency
Axel Heides Gade 1
2300 København S
Denmark
Tel. +45 7222 7400
E-mail: dkma@dkma.dk
www.laegemiddelstyrelsen.dk
Estonia
State Agency of
Medicines
1 Nooruse Street
50411 Tartu
Estonia
Tel. +372 737 41 40
Fax +372 737 41 42
E-mail: info@ravimiamet.ee
www.ravimiamet.ee
Finland
Finnish
Medicines
Agency
P.O. Box 55
FI-00034 FIMEA
Finland
Tel. +358 29 522 3341
Fax +358 9 4733 4339
www.fimea.fi
France
National
Agency for the
Safety of
Medicine and
Health Products
143-147 bd Anatole France
93285 Saint Denis cedex
France
Tel. +33 1 55 87 30 00
www.ansm.sante.fr
Germany
Federal Institute
for Drugs and
Medical
Devices
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Germany
Tel. +49 (0)228-207-30
Fax +49 (0)228-207-5207
E-mail: poststelle@bfarm.de
www.bfarm.de
Germany
Paul Ehrlich
Institute
Paul-Ehrlich-Straße 51-59
63225 Langen
Germany
Tel. +49 6103 77 0
Fax +49 6103 77 1234
E-mail: pei@pei.de
www.pei.de/
Greece
National
Organization
for Medicines
Messogion Avenue 284
15562 Athens
Greece
Tel. +30 213 2040 200
Fax +30 210 6545 535
E-mail: relation@eof.gr
www.eof.gr
Hungary
National
Institute of
Pharmacy and
Nutrition
Zrínyi U. 3
1051 Budapest
Hungary
Tel. +36 1 88 69 -300
Fax +36 1 88 69-460
E-mail: ogyei@ogyei.gov.hu
www.ogyei.gov.hu
Iceland
Icelandic
Medicines
Agency
Vínlandsleið 14
113 Reykjavík
Iceland
Tel. +354 520 2100
Fax +354 561 2170
E-mail: ima@ima.is
www.imca.is
Ireland
Health Products
Regulatory
Authority
(HPRA)
Kevin O'Malley House,
Earlsfort Centre,
Earlsfort Terrace,
Dublin 2,
Ireland
Tel. +353 1 676 4971
Fax +353 1 676 7836
E-mail: info@hpra.ie
www.hpra.ie
Italy
Italian
Medicines
Agency
Via del Tritone, 181
00187 Roma
Italy
Tel. +39 06 5978401
Fax +39 06 59784312
www.agenziafarmaco.it
Latvia
State Agency of
Medicines
15 Jersikas Street
1003 Riga
Latvia
Tel. +371 7078424
Fax +371 7078428
E-mail: info@zva.gov.lv
www.zva.gov.lv
Liechtenstein
Office of Health
/ Department of
Pharmaceuticals
Äulestr 512
9490 Vaduz
Liechtenstein
c
Lithuania
State Medicines
Control Agency
Žirmūnų g. 139A
09120 Vilnius
Lithuania
Tel. +370 5 263 9264
Tel +370 5 263 9265
E-mail: vvkt@vvkt.lt
www.vvkt.lt
Luxembourg
Ministry of
Health
Allée Marconi
2120 Luxembourg
Luxembourg
E-mail: ministere-sante@ms.etat.lu
www.ms.etat.lu
Malta
Medicines
Authority
203 Rue D´Argens
GZR 03 Gzira
Malta
Tel. +356 23439000
Fax +356 23439161
E-
mail: info.medicinesauthority@gov.
mt
www.medicinesauthority.gov.mt
Netherlands
Medicines
Evaluation
Board
Graadt van Roggenweg 500
3531 AH Utrecht
The Netherlands
Tel. +31 (0) 88 224 8000
Fax +31 (0) 88 224 8001
Contact: Submit your question
Netherlands
Healthcare
Inspectorate
Stadsplateau 1
3521 AZ Utrecht
The Netherlands
Tel. +31 88 120 5000
Fax +31 88 120 5001
E-mail: meldpunt@igz.nl
www.igz.nl
Norway
Norwegian
Medicines
Agency
Postboks 240 Skøyen
0213 Oslo
Norway
Tel. +47 22 89 77 00
E-mail: post@legemiddelverket.no
www.legemiddelverket.no
Poland
Office for
Registration of
Medicinal
Products,
Medical
Devices and
Biocidal
Products
Al. Jerozolimskie 181C
02-222 Warsaw
Poland
Tel. +48 (22) 492 11 00
Fax +48 (22) 492 11 09
www.urpl.gov.pl
Poland
Chief
Pharmaceutical
Inspectorate
Senatorska 12
00-082 Warsaw
Poland
Tel. +48 22 831 21 31
Fax +48 22 831 02 44
E-mail: gif@gif.gov.pl
www.gif.gov.pl
Portugal
National
Authority of
Medicines and
Health Products
Parque de Saúde de Lisboa -
Avenida do Brasil, 53
1749-004 Lisboa
Portugal
Tel. +351 217987100
Fax +351 217987316
E-mail: infarmed@infarmed.pt
www.infarmed.pt
Romania
National
Medicines
Agency
48, Av. Sanatescu
011478 Bucharest
Romania
Tel. +4021 317 11 00
Fax +4021 316 34 97
www.anm.ro
Slovakia
State Institute
for Drug
Control
Kvetná 11
825 08 Bratislava 26
Slovakia
Tel. +421 2 5070 1111
Fax +421 2 5556 4127
E-mail: sukl@sukl.sk
www.sukl.sk
Slovenia
Agency for
Medicinal
Products and
Medical
Devices of the
Republic of
Slovenia
Slovenčeva ulica 22
1000 Ljubljana
Slovenia
Tel. + 38 6 8 2000 500
Fax + 38 6 8 2000 510
E-mail: info@jazmp.si
www.jazmp.si
Spain
Spanish Agency
for Medicines
and Health
Products
Parque Empresarial
Las Mercedes Edificio 8C/.
Campezo, 1
28022 Madrid
Spain
www.aemps.gob.es
Sweden
Medical
Products
Agency
Dag Hammarskjölds väg 42 / Box 26
751 03 Uppsala
Sweden
Tel. +46 18 17 46 00
Fax +46 18 54 85 66
E-mail: registrator@mpa.se
www.lakemedelsverket.se
United
Kingdom
Medicines and
Healthcare
Products
Regulatory
Agency
151 Buckingham Palace Road
Victoria
London
SW1W 9SZ
United Kingdom
Tel. +44 (0)20 3080 6000
E-mail: info@mhra.gov.uk
www.mhra.gov.uk
MUTUAL RECOGNITION PROCEDURE (MRP)
 Only applicable if the applicant already has a national marketing authorization
 Not applicable to (biotech) products
 Procedure:
 Application to Reference Member State (RMS)
 First authorization granted by RMS
 Applicant requests mutual recognition
 Dossier consolidated for submission to other “concerned Member States
(CMS)
 Approval from CMS within 90 days
MUTUAL RECOGNITION PROCEDURE (MRP) - Time lines
DECENTRALIZED PROCEDURE (DCP)
 Available pathway if the product has no existing MA in any Member State
 Timeline for the DCP approval is 150 to 300 days
 Not applicable to (biotech) products
 Procedure:
 Identical dossiers sent to RMS and CMS
 RMS prepares preliminary assessment report and sends to CMS – Day 70
 CMS sends any comments to RMS –Day 100
 Clock-off period
 RMS prepares draft assessment report and sends to CMS – Day 120
 CMS sends any comments to RMS –Day 145
 RMS may close procedure if consensus reached –Day 150
 If RMS and CMS cannot reach agreement by Day 150 it referred to the
Coordination group for MRP and DCP for human medicinal products CMD (h)
DECENTRALIZED PROCEDURE (DCP) - Timelines
VARIATIONS
TYPE 1 VARIATION
(NOTIFICATION)
TYPE II VARIATION
• Change in composition of the
finished product
• Change in immediate packaging of
the finished product
TYPE 1A VARIATION
• Change in the name of
the active substance
• Change in ATC code
• Change in name of
address of the marketing
authorisation holder
TYPE 1B VARIATION
• Change in the name of
medicinal product
• Change in retest period of
active substance
• Change in storage
conditions for active
substance
EU REGULATORY SUBMISSIONS

More Related Content

What's hot

Variations to Marketing Authorization
Variations to Marketing AuthorizationVariations to Marketing Authorization
Variations to Marketing AuthorizationMangesh Gawade
 
EU Variations-Chandra.pptx
EU Variations-Chandra.pptxEU Variations-Chandra.pptx
EU Variations-Chandra.pptxChandra Mohan
 
Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)Prakash Ghimire
 
Plasma master file
Plasma master filePlasma master file
Plasma master fileSridhar S
 
US FDA post approval changes
US FDA post approval changesUS FDA post approval changes
US FDA post approval changesChandra Mohan
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...DeveshDRA
 
EU Variations & Renewals
EU Variations & RenewalsEU Variations & Renewals
EU Variations & RenewalsSachin Chede
 
Regulatory requirements of row countries
Regulatory requirements of row countriesRegulatory requirements of row countries
Regulatory requirements of row countriesDivya Pushp
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESVikas Rathee
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Nirma University
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYdatchayani
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationShoba Elangovan
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairsGirish Swami
 
Abriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingAbriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingshahnawazQuadir
 
Marketing authorization
Marketing authorizationMarketing authorization
Marketing authorizationsantoshnarla
 
Regulatory requirement for europe union
Regulatory requirement for europe unionRegulatory requirement for europe union
Regulatory requirement for europe unionShresthaPandey1
 

What's hot (20)

Variations to Marketing Authorization
Variations to Marketing AuthorizationVariations to Marketing Authorization
Variations to Marketing Authorization
 
EU Variations-Chandra.pptx
EU Variations-Chandra.pptxEU Variations-Chandra.pptx
EU Variations-Chandra.pptx
 
Regulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in EuropeRegulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in Europe
 
Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)Dossier Preparation/ CTD (Common Technical Document)
Dossier Preparation/ CTD (Common Technical Document)
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
US FDA post approval changes
US FDA post approval changesUS FDA post approval changes
US FDA post approval changes
 
eCTD
eCTDeCTD
eCTD
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
 
EU Variations & Renewals
EU Variations & RenewalsEU Variations & Renewals
EU Variations & Renewals
 
Regulatory requirements of row countries
Regulatory requirements of row countriesRegulatory requirements of row countries
Regulatory requirements of row countries
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairs
 
Abriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingAbriviated new drug application 505(j) filling
Abriviated new drug application 505(j) filling
 
eCTD Submissions
eCTD SubmissionseCTD Submissions
eCTD Submissions
 
Marketing authorization
Marketing authorizationMarketing authorization
Marketing authorization
 
Regulatory requirement for europe union
Regulatory requirement for europe unionRegulatory requirement for europe union
Regulatory requirement for europe union
 

Similar to EU REGULATORY SUBMISSIONS

Regulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptxRegulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptxArindamGhosh828861
 
European medicines agency
European medicines agencyEuropean medicines agency
European medicines agencyVicky Vignesh
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGAHimal Barakoti
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptxREGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptxBharatRRDesai
 
Regulatory Agencies EU and MHRA.pptx
Regulatory Agencies EU and MHRA.pptxRegulatory Agencies EU and MHRA.pptx
Regulatory Agencies EU and MHRA.pptxAnkushAwatale
 
Analysing the EU PVG regulations
Analysing the EU PVG regulationsAnalysing the EU PVG regulations
Analysing the EU PVG regulationsUntil ROI
 
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1]  -  Read-Only.pptxCLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1]  -  Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptxMayur Patil
 
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Manukonda sravani Reddy
 
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxREGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxShivamKumar740
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGAAshwiniBawankule
 
Marketing authorisations in the European Union
Marketing authorisations in the European UnionMarketing authorisations in the European Union
Marketing authorisations in the European UnionFrancois MAIGNEN
 
Neo stop 300 hn msds
Neo stop 300 hn msdsNeo stop 300 hn msds
Neo stop 300 hn msdsarysta123
 
EU Pharmacovigilance legislation
EU Pharmacovigilance legislation EU Pharmacovigilance legislation
EU Pharmacovigilance legislation Arete-Zoe, LLC
 
Regulatory requirments of eu, tga & row countries
Regulatory requirments of eu, tga  & row countriesRegulatory requirments of eu, tga  & row countries
Regulatory requirments of eu, tga & row countriesGeetaKhillari
 
European medicines evaluation agency
European medicines evaluation agencyEuropean medicines evaluation agency
European medicines evaluation agencyGaurav Sharma
 
Regulatory requirements of eu & mhra trilok
Regulatory requirements of eu & mhra  trilokRegulatory requirements of eu & mhra  trilok
Regulatory requirements of eu & mhra trilokTrilok Shahare
 

Similar to EU REGULATORY SUBMISSIONS (20)

Regulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptxRegulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptx
 
European medicines agency
European medicines agencyEuropean medicines agency
European medicines agency
 
Emea
EmeaEmea
Emea
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
 
EMEA
EMEAEMEA
EMEA
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptxREGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
 
Regulatory Agencies EU and MHRA.pptx
Regulatory Agencies EU and MHRA.pptxRegulatory Agencies EU and MHRA.pptx
Regulatory Agencies EU and MHRA.pptx
 
Analysing the EU PVG regulations
Analysing the EU PVG regulationsAnalysing the EU PVG regulations
Analysing the EU PVG regulations
 
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1]  -  Read-Only.pptxCLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1]  -  Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
 
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptxEUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptx
 
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
Indian Pharmaceutical Industry; its Challenges WHILE Exportation of pharmaceu...
 
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptxREGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptx
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGA
 
Marketing authorisations in the European Union
Marketing authorisations in the European UnionMarketing authorisations in the European Union
Marketing authorisations in the European Union
 
Neo stop 300 hn msds
Neo stop 300 hn msdsNeo stop 300 hn msds
Neo stop 300 hn msds
 
EU Pharmacovigilance legislation
EU Pharmacovigilance legislation EU Pharmacovigilance legislation
EU Pharmacovigilance legislation
 
Regulatory requirments of eu, tga & row countries
Regulatory requirments of eu, tga  & row countriesRegulatory requirments of eu, tga  & row countries
Regulatory requirments of eu, tga & row countries
 
An introduction to the EMA
An introduction to the EMAAn introduction to the EMA
An introduction to the EMA
 
European medicines evaluation agency
European medicines evaluation agencyEuropean medicines evaluation agency
European medicines evaluation agency
 
Regulatory requirements of eu & mhra trilok
Regulatory requirements of eu & mhra  trilokRegulatory requirements of eu & mhra  trilok
Regulatory requirements of eu & mhra trilok
 

More from Chandra Mohan

Introduction to the ICH Guidelines
Introduction to the ICH GuidelinesIntroduction to the ICH Guidelines
Introduction to the ICH GuidelinesChandra Mohan
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in IndiaChandra Mohan
 
Comparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & EuropeComparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & EuropeChandra Mohan
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESChandra Mohan
 
ICH eCTD specification
ICH eCTD specificationICH eCTD specification
ICH eCTD specificationChandra Mohan
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairsChandra Mohan
 
ICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra MohanICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra MohanChandra Mohan
 
Regulatory Affairs by Chandra Mohan
Regulatory Affairs by Chandra MohanRegulatory Affairs by Chandra Mohan
Regulatory Affairs by Chandra MohanChandra Mohan
 

More from Chandra Mohan (10)

Introduction to the ICH Guidelines
Introduction to the ICH GuidelinesIntroduction to the ICH Guidelines
Introduction to the ICH Guidelines
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Comparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & EuropeComparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & Europe
 
EU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGESEU POST-APPROVAL CHANGES
EU POST-APPROVAL CHANGES
 
ICH eCTD specification
ICH eCTD specificationICH eCTD specification
ICH eCTD specification
 
eCTD
eCTDeCTD
eCTD
 
CTD structure
CTD structureCTD structure
CTD structure
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairs
 
ICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra MohanICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra Mohan
 
Regulatory Affairs by Chandra Mohan
Regulatory Affairs by Chandra MohanRegulatory Affairs by Chandra Mohan
Regulatory Affairs by Chandra Mohan
 

Recently uploaded

Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...narwatsonia7
 
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...rajnisinghkjn
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any TimeCall Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Timevijaych2041
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Modelssonalikaur4
 

Recently uploaded (20)

Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
 
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
 
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...
Dwarka Sector 6 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few Cl...
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any TimeCall Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
 

EU REGULATORY SUBMISSIONS

  • 2. • Introduction • European union member states • Committees of EMEA • Marketing authorization procedures  Centralized procedure (CP)  National procedure (NP)  Mutual recognition procedure (MRP)  Decentralized procedure (DCP)
  • 4. Introduction to the EMA • Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA) • The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in London. It began operating in 1995. The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU. • EMA protects public and animal health in 28 EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.
  • 5. European union member states Belgium (BE) Greece (EL) Lithuania (LT) Portugal (PT) Bulgaria (BG) Spain (ES) Luxembourg (LU) Romania (RO) Czech Republic (CZ) France (FR) Hungary (HU) Slovenia (SI) Denmark (DK) Croatia (HR) Malta (MT) Slovakia (SK) Germany (DE) Italy (IT) Netherlands (NL) Finland (FI) Estonia (EE) Cyprus (CY) Austria (AT) Sweden (SE) Ireland (IE) Latvia (LV) Poland (PL) United Kingdom (UK) European free trade association Iceland (IS) Norway (NO) Liechtenstein (LI) Switzerland (CH)
  • 6. United Kingdom’s (UK) withdrawal from the EU • EMA has published important information to help users of the centralised procedure prepare for the expected consequences of 'Brexit', including their obligations related to establishment within the European Economic Area (EEA). For more information, see UK’s withdrawal from the EU. • On 29 March 2017, the United Kingdom (UK) notified the European Council of its intention to withdraw from the European Union (EU), a process known as 'Brexit'. The European Medicines Agency (EMA) is making preparations to ensure that it can continue to deliver on its mission and protect public and animal health after the UK leaves the EU on 30 March 2019, the date currently set by the timeframe provided in Article 50 of the Treaty on European Union. • One of the consequences of Brexit is that EMA will relocate to Amsterdam, the Netherlands, where it has to take up its operations on 30 March 2019 at the latest.
  • 7. REGULATORY BODY - EMA  European medical Agency (EMA):  Decentralized body of EU with headquarters in London (going to move Amsterdam)  Protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use  There are 7 scientific committees works under EMA in EU and EEA- EFTA
  • 8. Committees of EMEA Committee for Medicinal Products for Human Use (CHMP) Pharmacovigilance Risk Assessment Committee (PRAC)  Committee for Medicinal Products for Veterinary Use (CVMP)  Committee for Orphan Medicinal Products (COMP)  Committee on Herbal Medicinal Products (HMPC)  Pediatric Committee (PDCO)  Committee for Advanced Therapies (CAT)
  • 9. MARKETING AUTHORIZATION PROCEDURES  CENTRALIZED PROCEDURE (CP)  NATIONAL PROCEDURE (NP)  MUTUAL RECOGNITION PROCEDURE (MRP)  DECENTRALIZED PROCEDURE (DCP)
  • 10. CENTRALIZED PROCEDURE  Under the centralised authorisation procedure, pharmaceutical companies submit a single marketing-authorisation application to EMA.  This allows the marketing-authorisation holder to market the medicine throughout the EU.  MA's Committee for Medicinal products for Human Use (CHMP) or Committee for Medicinal products for Veterinary Use (CVMP) carry out a scientific assessment of the application and give a recommendation on whether the medicine should be marketed or not.  Once granted by the European Commission, the centralised marketing authorisation is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway.
  • 12. The centralised procedure is mandatory for:  Human medicines containing a new active substance to treat: HIV or AIDS; Cancer; Diabetes; Neurodegenerative diseases; Viral diseases; auto-immune and other immune dysfunctions;  Medicines derived from biotechnology processes, such as genetic engineering;  Advanced-therapy medicines such as gene-therapy, somatic cell-therapy or tissue- engineered medicines;  Orphan medicines (medicines for rare diseases);  Veterinary medicines for use as growth or yield enhancers. CENTRALIZED PROCEDURE
  • 14. NATIONAL PROCEDURE  Marketing authorization in one particular EU country  Each EU Member State has its own national authorisation procedures.  Approval time for drug product varies within member states of EU  Applicable to abridged drug products  Not applicable to biotechnology products  Can also serve as the first phase of a Mutual Recognition procedure  National abridged standard and complex applications takes approximately 210 days to be approved in UK List of national competent authorities in the EEA:
  • 15. Country Name Contact details Logo Austria Austrian Agency for Health and Food Safety Spargelfeldstraße 191 1220 Wien Austria Tel. +43 5 0555-0 Fax +43 5 0555-22019 www.ages.at Belgium Federal Agency for Medicines and Health Products Eurostation building, block 2 place Victor Horta, 40/ 40 1060 Brussels Belgium Tel. +32 2 524 7111 E-mail: info.medicines@fagg- afmps.be www.fagg-afmps.be/ Bulgaria Bulgarian Drug Agency 8 Damyan Gruev Str. Sofia 1303 Bulgaria Tel. +359 2 890 35 55 Fax +359 2 890 34 34 E-mail: bda@bda.bg www.bda.bg Croatia Agency for medicinal products and medical devices of Croatia Ksaverska cesta 4 10 000 Zagreb Tel. +385 1 4884 100 Fax: +385 1 4884 110 E-mail: halmed@halmed.hr www.almp.hr Cyprus Ministry of Health - Pharmaceutical Services Pharmaceutical Services Ministry of Health 1475 Nicosia Cyprus Tel: +357 22608620 Fax: +357 22608649 E-mail: phscentral@phs.moh.gov.cy www.moh.gov.cy/phs Czech Republic State Institute for Drug Control Srobárova 48 100 41 Praha 10 Czech Republic Tel. +420 272 185 333 Fax +420 272 185 756 E-mail: infs@sukl.cz www.sukl.cz Denmark Danish Medicines Agency Axel Heides Gade 1 2300 København S Denmark Tel. +45 7222 7400 E-mail: dkma@dkma.dk www.laegemiddelstyrelsen.dk
  • 16. Estonia State Agency of Medicines 1 Nooruse Street 50411 Tartu Estonia Tel. +372 737 41 40 Fax +372 737 41 42 E-mail: info@ravimiamet.ee www.ravimiamet.ee Finland Finnish Medicines Agency P.O. Box 55 FI-00034 FIMEA Finland Tel. +358 29 522 3341 Fax +358 9 4733 4339 www.fimea.fi France National Agency for the Safety of Medicine and Health Products 143-147 bd Anatole France 93285 Saint Denis cedex France Tel. +33 1 55 87 30 00 www.ansm.sante.fr Germany Federal Institute for Drugs and Medical Devices Kurt-Georg-Kiesinger-Allee 3 53175 Bonn Germany Tel. +49 (0)228-207-30 Fax +49 (0)228-207-5207 E-mail: poststelle@bfarm.de www.bfarm.de Germany Paul Ehrlich Institute Paul-Ehrlich-Straße 51-59 63225 Langen Germany Tel. +49 6103 77 0 Fax +49 6103 77 1234 E-mail: pei@pei.de www.pei.de/ Greece National Organization for Medicines Messogion Avenue 284 15562 Athens Greece Tel. +30 213 2040 200 Fax +30 210 6545 535 E-mail: relation@eof.gr www.eof.gr Hungary National Institute of Pharmacy and Nutrition Zrínyi U. 3 1051 Budapest Hungary Tel. +36 1 88 69 -300 Fax +36 1 88 69-460 E-mail: ogyei@ogyei.gov.hu www.ogyei.gov.hu
  • 17. Iceland Icelandic Medicines Agency Vínlandsleið 14 113 Reykjavík Iceland Tel. +354 520 2100 Fax +354 561 2170 E-mail: ima@ima.is www.imca.is Ireland Health Products Regulatory Authority (HPRA) Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland Tel. +353 1 676 4971 Fax +353 1 676 7836 E-mail: info@hpra.ie www.hpra.ie Italy Italian Medicines Agency Via del Tritone, 181 00187 Roma Italy Tel. +39 06 5978401 Fax +39 06 59784312 www.agenziafarmaco.it Latvia State Agency of Medicines 15 Jersikas Street 1003 Riga Latvia Tel. +371 7078424 Fax +371 7078428 E-mail: info@zva.gov.lv www.zva.gov.lv Liechtenstein Office of Health / Department of Pharmaceuticals Äulestr 512 9490 Vaduz Liechtenstein c Lithuania State Medicines Control Agency Žirmūnų g. 139A 09120 Vilnius Lithuania Tel. +370 5 263 9264 Tel +370 5 263 9265 E-mail: vvkt@vvkt.lt www.vvkt.lt
  • 18. Luxembourg Ministry of Health Allée Marconi 2120 Luxembourg Luxembourg E-mail: ministere-sante@ms.etat.lu www.ms.etat.lu Malta Medicines Authority 203 Rue D´Argens GZR 03 Gzira Malta Tel. +356 23439000 Fax +356 23439161 E- mail: info.medicinesauthority@gov. mt www.medicinesauthority.gov.mt Netherlands Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands Tel. +31 (0) 88 224 8000 Fax +31 (0) 88 224 8001 Contact: Submit your question Netherlands Healthcare Inspectorate Stadsplateau 1 3521 AZ Utrecht The Netherlands Tel. +31 88 120 5000 Fax +31 88 120 5001 E-mail: meldpunt@igz.nl www.igz.nl Norway Norwegian Medicines Agency Postboks 240 Skøyen 0213 Oslo Norway Tel. +47 22 89 77 00 E-mail: post@legemiddelverket.no www.legemiddelverket.no Poland Office for Registration of Medicinal Products, Medical Devices and Biocidal Products Al. Jerozolimskie 181C 02-222 Warsaw Poland Tel. +48 (22) 492 11 00 Fax +48 (22) 492 11 09 www.urpl.gov.pl
  • 19. Poland Chief Pharmaceutical Inspectorate Senatorska 12 00-082 Warsaw Poland Tel. +48 22 831 21 31 Fax +48 22 831 02 44 E-mail: gif@gif.gov.pl www.gif.gov.pl Portugal National Authority of Medicines and Health Products Parque de Saúde de Lisboa - Avenida do Brasil, 53 1749-004 Lisboa Portugal Tel. +351 217987100 Fax +351 217987316 E-mail: infarmed@infarmed.pt www.infarmed.pt Romania National Medicines Agency 48, Av. Sanatescu 011478 Bucharest Romania Tel. +4021 317 11 00 Fax +4021 316 34 97 www.anm.ro Slovakia State Institute for Drug Control Kvetná 11 825 08 Bratislava 26 Slovakia Tel. +421 2 5070 1111 Fax +421 2 5556 4127 E-mail: sukl@sukl.sk www.sukl.sk Slovenia Agency for Medicinal Products and Medical Devices of the Republic of Slovenia Slovenčeva ulica 22 1000 Ljubljana Slovenia Tel. + 38 6 8 2000 500 Fax + 38 6 8 2000 510 E-mail: info@jazmp.si www.jazmp.si Spain Spanish Agency for Medicines and Health Products Parque Empresarial Las Mercedes Edificio 8C/. Campezo, 1 28022 Madrid Spain www.aemps.gob.es
  • 20. Sweden Medical Products Agency Dag Hammarskjölds väg 42 / Box 26 751 03 Uppsala Sweden Tel. +46 18 17 46 00 Fax +46 18 54 85 66 E-mail: registrator@mpa.se www.lakemedelsverket.se United Kingdom Medicines and Healthcare Products Regulatory Agency 151 Buckingham Palace Road Victoria London SW1W 9SZ United Kingdom Tel. +44 (0)20 3080 6000 E-mail: info@mhra.gov.uk www.mhra.gov.uk
  • 21. MUTUAL RECOGNITION PROCEDURE (MRP)  Only applicable if the applicant already has a national marketing authorization  Not applicable to (biotech) products  Procedure:  Application to Reference Member State (RMS)  First authorization granted by RMS  Applicant requests mutual recognition  Dossier consolidated for submission to other “concerned Member States (CMS)  Approval from CMS within 90 days
  • 22. MUTUAL RECOGNITION PROCEDURE (MRP) - Time lines
  • 23. DECENTRALIZED PROCEDURE (DCP)  Available pathway if the product has no existing MA in any Member State  Timeline for the DCP approval is 150 to 300 days  Not applicable to (biotech) products  Procedure:  Identical dossiers sent to RMS and CMS  RMS prepares preliminary assessment report and sends to CMS – Day 70  CMS sends any comments to RMS –Day 100  Clock-off period  RMS prepares draft assessment report and sends to CMS – Day 120  CMS sends any comments to RMS –Day 145  RMS may close procedure if consensus reached –Day 150  If RMS and CMS cannot reach agreement by Day 150 it referred to the Coordination group for MRP and DCP for human medicinal products CMD (h)
  • 25. VARIATIONS TYPE 1 VARIATION (NOTIFICATION) TYPE II VARIATION • Change in composition of the finished product • Change in immediate packaging of the finished product TYPE 1A VARIATION • Change in the name of the active substance • Change in ATC code • Change in name of address of the marketing authorisation holder TYPE 1B VARIATION • Change in the name of medicinal product • Change in retest period of active substance • Change in storage conditions for active substance